Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy

Author(s):
Signorelli, M. (0000-0002-8102-3356); Ayoglu, B.; Johansson, C.; Lochmuller, H.; Straub, V.; Muntoni, F.; Niks, E.; Tsonaka, R.; Persson, A.; Aartsma-Rus, A.; Nilsson, P.; Al-Khalili Szigyarto, C.; Spitali, P.
Published
2019
Publication type
Article / Letter to editor
Duchenne muscular dystrophyProtein biomarkersPrognostic biomarkerRare diseasesSerum biomarkers
Date issued
2019-12-27
Language
English
Is part of
Journal of Cachexia, Sarcopenia and Muscle
hdl
1887/121423
doi
10.1002/jcsm.12517